© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Kashyap Patel, MD, discusses the need for provider education on biosimilars.
Transcript:
Basically, we need to educate our colleagues about the science of biosimilars: how they’re developed, how they’re equal, and how the FDA has put in very rigorous standards for evaluating the safety, efficacy, and similarity of the biosimilar molecule to the originator molecule.